Receptors for fibroblast growth factors - PubMed (original) (raw)
Review
Receptors for fibroblast growth factors
J C Coutts et al. Immunol Cell Biol. 1995 Dec.
Abstract
The recent discovery of the involvement of heparan sulfate proteoglycans (HSPG) in the activation of fibroblast growth factor receptors (FGFR) has led to an intensification of study of this field. It appears that the HSPG act as low affinity receptors to which the fibroblast growth factors (FGF) must bind in order to successfully activate the high affinity FGFR. Heparan sulfate chains consisting of alternately arranged N-acetylated or N-sulfated glucosamine and uronic acid disaccharide regions, covalently attached to a core protein are found in two major families of cell surface HSPG, the syndecans and glypicans. A high affinity bFGF binding region has been isolated from fibroblast HS. There are four basic members of the FGFR family (FGFR 1-4), as well as a wealth of splice variants. The alternative forms of the basic receptors can have altered ligand binding or signalling qualities, depending on the region of the gene which is spliced. Investigations with null FGFR, incapable of signalling, have demonstrated the requirement for FGF in the organization of mammalian tissues and in embryonic patterning. Mutation of the FGFR genes has been recognized recently in human craniosynostoses where a single base pair mutation in the FGFR gene results in skeletal malformations specific to each syndrome. One suggestion is that the interaction of the mutant FGFR with the HSPG/FGF complex somehow contributes to the disease phenotype.
Similar articles
- Insights into the role of heparan sulphate in fibroblast growth factor signalling.
Harmer NJ. Harmer NJ. Biochem Soc Trans. 2006 Jun;34(Pt 3):442-5. doi: 10.1042/BST0340442. Biochem Soc Trans. 2006. PMID: 16709182 Review. - Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL, Kan M. McKeehan WL, et al. Mol Reprod Dev. 1994 Sep;39(1):69-81; discusison 81-2. doi: 10.1002/mrd.1080390112. Mol Reprod Dev. 1994. PMID: 7999363 Review. - Structural basis for fibroblast growth factor receptor activation.
Mohammadi M, Olsen SK, Ibrahimi OA. Mohammadi M, et al. Cytokine Growth Factor Rev. 2005 Apr;16(2):107-37. doi: 10.1016/j.cytogfr.2005.01.008. Cytokine Growth Factor Rev. 2005. PMID: 15863029 Review. - Role of heparan sulfate in fibroblast growth factor signalling: a structural view.
Pellegrini L. Pellegrini L. Curr Opin Struct Biol. 2001 Oct;11(5):629-34. doi: 10.1016/s0959-440x(00)00258-x. Curr Opin Struct Biol. 2001. PMID: 11785766 Review.
Cited by
- Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview.
Yang W, Sun Y. Yang W, et al. Onco Targets Ther. 2021 Feb 25;14:1341-1366. doi: 10.2147/OTT.S297643. eCollection 2021. Onco Targets Ther. 2021. PMID: 33658799 Free PMC article. Review. - Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders.
Sarode GS, Sarode SC, Maniyar N, Sharma N, Yerwadekar S, Patil S. Sarode GS, et al. Oncol Rev. 2019 Sep 10;13(2):424. doi: 10.4081/oncol.2019.424. eCollection 2019 Jul 22. Oncol Rev. 2019. PMID: 31565195 Free PMC article. - Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials.
Simile MM, Bagella P, Vidili G, Spanu A, Manetti R, Seddaiu MA, Babudieri S, Madeddu G, Serra PA, Altana M, Paliogiannis P. Simile MM, et al. Medicina (Kaunas). 2019 Feb 8;55(2):42. doi: 10.3390/medicina55020042. Medicina (Kaunas). 2019. PMID: 30743998 Free PMC article. Review. - FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome.
Lin Y, Gao H, Ai S, Eswarakumar JVP, Zhu Y, Chen C, Li T, Liu B, Jiang H, Liu Y, Li Y, Wu Q, Li H, Liang X, Jin C, Huang X, Lu L. Lin Y, et al. Mol Med Rep. 2017 Nov;16(5):5841-5846. doi: 10.3892/mmr.2017.7397. Epub 2017 Aug 29. Mol Med Rep. 2017. PMID: 28901406 Free PMC article. - Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S, Goel MM, Makker A, Bhatia V, Chandra S, Kumar S, Agarwal SP. Nayak S, et al. PLoS One. 2015 Oct 14;10(10):e0138801. doi: 10.1371/journal.pone.0138801. eCollection 2015. PLoS One. 2015. PMID: 26465941 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources